Editorial: Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice

Editorial: Molecular markers for pancreatic cancers: new technologies and applications in the clinical practice

Saved in:

Bibliographic Details
Main Authors:	Terence Moyana, Valeria Merz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	pancreatic ductal adenocarcinoma molecular markers circulating biomarkers exosomes major vault protein transcriptomic tools
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651566/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
by: Ronit Juthani, et al.
Published: (2025-04-01)

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
by: Metoboroghene O. Mowoe, et al.
Published: (2025-01-01)

Proteomics in pancreatic cancer
by: Fei Cai, et al.
Published: (2025-07-01)

Serum-derived exosomal miR-7977 combined with miR-451a as a potential biomarker for pancreatic ductal adenocarcinoma
by: Jia Chen, et al.
Published: (2025-02-01)

Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information
by: Kokichi Miyamoto, et al.
Published: (2025-08-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Assessment of Vault Particles in Cancer Cell Line‐Derived Extracellular Vesicle Preparations
by: Xinming Liu, et al.
Published: (2025-08-01)

A case of pancreatic head cancer with Trousseau’s syndrome treated with radical resection and anticoagulant therapy
by: Takumi Kitahama, et al.
Published: (2023-01-01)

Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
by: Ulrich Nitsche, et al.
Published: (2016-01-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Abnormalities in T cell subsets in the circulating immunity and tumor microenvironment in patients with pancreatic ductal adenocarcinoma
by: SU Bingwei, SHEN Baiyong
Published: (2025-03-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma
by: Takeaki Nakamura, et al.
Published: (2025-05-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Inflammation, microbiota, and pancreatic cancer
by: XiaoLiang Chen, et al.
Published: (2025-02-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)

Nanomedicine in the Diagnosis and Treatment of Pancreatic Cancer
by: Kexin Guo, et al.
Published: (2025-03-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis
by: Xiaohong Liu, et al.
Published: (2025-08-01)

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma
by: Benjamin Stubbe, et al.
Published: (2025-05-01)

Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma
by: Yuqi Zhang, et al.
Published: (2025-05-01)

Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
by: Dimitrios Papakonstantinou, et al.
Published: (2025-01-01)

Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis
by: Shuhei Shinoda, et al.
Published: (2025-07-01)

Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)

Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities
by: Zijin Lin, et al.
Published: (2025-07-01)

Artificial intelligence in pancreatic cancer histopathology and diagnostics - implications for clinical decisions and biomarker discovery?
by: Petra Weselá, et al.
Published: (2025-06-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01)

Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer
by: Qi-Wen Wang, et al.
Published: (2025-03-01)

Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-08-01)

Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening
by: Yue Huang, et al.
Published: (2025-08-01)

Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes
by: Robert Michael O’Connell, et al.
Published: (2025-07-01)

Prevention of pancreatic cancer
by: Stefan Kuroczycki-Saniutycz, et al.
Published: (2017-02-01)

A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases
by: Yaheng Wu, et al.
Published: (2025-07-01)

Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans
by: Raquel Santana da Cruz, et al.
Published: (2025-07-01)

Machine learning identifies 6-gene signature in peripheral blood for pancreatic cancer diagnosis
by: Francisco Carrillo-Perez, et al.
Published: (2025-07-01)

Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer
by: Minoru Kitago, et al.
Published: (2024-07-01)

Protein kinase R regulates pancreatic ductal adenocarcinoma progression by modulating the cell cycle via GADD45A
by: Yuki Numata, et al.
Published: (2025-07-01)